| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d07c340ab610a53c7c834dbc25047580
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec57e6016f54b2b28b86215c2066e8d1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00 |
| filingDate |
2018-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e90fe84b3478ce42e7985ab68761c2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c0492dcc32f8333b54ae0ecebb0bb83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_270cab98f00d13fdd9c12672849fdcd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1882a6b1e566c7642d34a088602cb72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f25bec41864f20e980c602378b64ede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5141114a48c61f9c3b97490df6f0658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31695fe9fa5dc04163844b25431a60eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bada96bd70749aed2fbbb95feac9b73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_345ec0afacc62af735573e4762417935 |
| publicationDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020102339-A1 |
| titleOfInvention |
Sulphated Disaccharides for the Treatment of Neuropathic Pain |
| abstract |
The present invention relates to sulphated disaccharides of formula (I) for use in the treatment of neuropathic pain. The present invention also relates to a pharmaceutical composition comprising the compound of formula (I) and at least one pharmaceutically acceptable excipient for use in the treatment of neuropathic pain. The compounds of formula (I) were effective in several experimental models of neuropathic pain for which reason these compounds can be used effectively for the treatment of different types of neuropathic pain and the clinical manifestations thereof, for example, mechanical allodynia or cold allodynia. |
| priorityDate |
2017-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |